Tirzepatide is a 39amino acid dual incretin receptor agonist that activates both GLP1 and GIP receptors, enhancing glucosedependent insulin secretion, suppressing glucagon, slowing gastric emptying, and reducing appetite [1] [2]
A smaller needle (25-27G) is ideal for the actual injection, as it causes less tissue trauma and is more comfortable
Pregnant or breastfeeding women should not use AOD-9604 due to lack of safety data in these populations
As the first treatment strategy, conventional synthetic (cs) DMARDs like methotrexate, hydroxychloroquine, sulfasalazine, leflunomide, chloroquine, and gold salts should be used as soon as RA is diagnosed
Once punctured, bacteriostatic water is generally considered stable for up to 28 days when stored at recommended laboratory conditions, though researchers should always follow their own protocols stability guidance